| . "Genetic association analysis under complex survey sampling: the Hispanic Community Health Study/Study of Latinos.." Am J Hum Genet. 2014;95(6):675-88. Pub Med |
| . "Survival benefit of lung transplantation in the modern era of lung allocation.." Ann Am Thorac Soc. 2017;14(2):172-181. Pub Med |
| . "Assessing the causal effect of organ transplantation on the distribution of residual lifetime.." Biometrics. 2013;69(4):820-9. Pub Med |
| . "Robust test method for time-course microarray experiments.." BMC Bioinformatics. 2010;11():391. Pub Med |
| . "Bayesian estimation of semiparametric nonlinear dynamic factor analysis models using the Dirichlet process prior.." Br J Math Stat Psychol. 2011;64(Pt 1):69-106. Pub Med |
| . "Latent class model characterization of neighborhood socioeconomic status.." Cancer Causes Control. 2016;27(3):445-52. Pub Med |
| . "Common variants in psychiatric risk genes predict brain structure at birth.." Cereb Cortex. 2014;24(5):1230-46. Pub Med |
| . "Genomewide meta-analysis validates a role for S1PR1 in microtubule targeting agent-induced sensory peripheral neuropathy.." Clin Pharmacol Ther. 2020;108(3):625-634. Pub Med |
| . "Increase in speech recognition due to linguistic mismatch between target and masker speech: monolingual and simultaneous bilingual performance.." J Speech Lang Hear Res. 2014;57(3):1089-97. Pub Med |
| . "Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer.." J Thorac Oncol. 2015;10(7):1099-106. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "Validation of progression-free survival as a surrogate endpoint for overall survival in malignant mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.." Oncologist. 2017;22(2):189-198. Pub Med |
| . "Genetic variation determines VEGF-A plasma levels in cancer patients.." Sci Rep. 2018;8(1):16332. Pub Med |
